Praxis Precision Medicines (PRAX) Total Current Liabilities (2019 - 2026)

Praxis Precision Medicines' Total Current Liabilities history runs 8 years deep, the most recent figure standing at $50.2 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 27.12% year-over-year to $50.2 million; the TTM figure through Mar 2026 stood at $50.2 million (up 27.12% YoY), while the FY2025 annual figure was $59.8 million, up 59.18% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $50.2 million, down from $59.8 million in the prior quarter.
• The five-year high for Total Current Liabilities was $59.8 million in Q4 2025, with the low at $15.7 million in Q4 2023.
• The 5-year median for Total Current Liabilities is $34.3 million (2022), against an average of $35.0 million.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities soared 229.18% in 2022, then sank 54.14% in 2023.
• Praxis Precision Medicines' Total Current Liabilities stood at $34.3 million in 2022, then tumbled by 54.14% to $15.7 million in 2023, then jumped by 138.43% to $37.6 million in 2024, then jumped by 59.18% to $59.8 million in 2025, then decreased by 15.94% to $50.2 million in 2026.
• Business Quant data shows PRAX's Total Current Liabilities at $50.2 million in Q1 2026, $59.8 million in Q4 2025, and $52.9 million in Q3 2025.